Related Experiment Video
Updated: Jan 23, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Therapy for anogenital verrucae in preadolescent children with topical and systemic treatment
Bahir H Chamseddin1, Nnenna G Agim1, Jason Jarin2
1Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Insights
Sinecatechins 15% ointment and imiquimod 5% cream show moderate effectiveness for treating anogenital warts (AV) in children. Sinecatechins demonstrated a trend toward greater efficacy, with both treatments having mild side effects.
Area of Science:
- Dermatology
- Pediatric Medicine
- Virology
Background:
- Anogenital verrucae (AV) are common, benign human papillomavirus (HPV)-induced growths.
- Medical treatment options for pediatric AV are not extensively studied.
- Evaluating topical therapies for efficacy and safety in preadolescents is crucial.
Purpose of the Study:
- To assess the efficacy and safety of sinecatechins 15% ointment and imiquimod 5% cream for treating AV in children under 12.
- To compare the effectiveness of these topical agents when used alone or in combination with other therapies.
- To determine the side effect profile of each treatment modality.
Main Methods:
- Retrospective review of 37 pediatric patients with AV treated at a single institution.
- Analysis of demographic data, treatment outcomes, and adverse events.
- Comparison of treatment responses between sinecatechins, imiquimod, and combination therapies.
Main Results:
- Sinecatechins showed a response in 8/9 patients (5 full, 3 partial).
- Imiquimod showed a response in 9/17 patients (4 full, 5 partial).
- No combination therapy demonstrated superior efficacy; side effects were mild (irritation, erythema).
Conclusions:
- Both sinecatechins and imiquimod are moderately effective for pediatric AV treatment.
- Sinecatechins exhibited a trend towards higher effectiveness compared to imiquimod.
- Topical treatments offer a tolerable safety profile with low complication risk for children.
Background/Objectives:
Anogenital verrucae (AV) are benign, human papillomavirus (HPV)-induced tumors of the anogenital skin and mucosa. Medical therapy for AV in preadolescents has not been well studied. We explore the efficacy and safety profile of sinecatechins 15% ointment and imiquimod 5% cream in the treatment of AV, alone and in combination therapy with other commonly used medications.
Methods:
A single-institution, retrospective review of children under 12 years of age with AV treated with imiquimod 5% cream and sinecatechins 15% ointment was performed. Demographic data, side effects, and outcomes of therapy were recorded for each patient, and overall efficacy was determined.
Results:
A total of 37 patients met inclusion criteria. Responses were seen in 8 out of 9 patients treated with sinecatechins 15% ointment (5 full, 3 partial, and 1 no response) and 9 out of 17 patients treated with imiquimod 5% cream (4 full, 5 partial, and 8 no response). Combination therapy with one or more of the following treatments (podophyllin, cimetidine, candida antigen injection, and HPV vaccine) were evaluated, but no combination was objectively superior to the others. No significant difference was found in overall efficacy between sinecatechins and imiquimod. Side effects were mild and limited to irritation and erythema.
Conclusions:
Both imiquimod 5% cream and sinecatechins 15% ointment are moderately effective in the treatment of AV in preadolescent children, with a trend toward greater effectiveness of sinecatechins. Combination therapy with other treatments did not significantly increase the effectiveness of topical therapies. Each modality has a tolerable side effect profile with a low risk of serious complications.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Gene Therapy
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Group Therapy

